Atezolizumab,Bevacizumab
Roche
['bevacizumab', 'atezo']
the combination of atezolizumab plus bevacizumab as adjuvant therapy after surgical resection in hepatocellular carcinoma appears to improve recurrence-free survival, according to results presented at #aacr23 
the limbic aims to provide medical oncologists with easy access to clinical and research news relevant to their specialty.